data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Halozyme Therapeutics
(NASDAQ:HALO)
$44.48
0.48[1.09%]
At close: Jul 1
$44.48
00
After Hours: 4:30PM EDT
Day High/Low43.46 - 44.64
52 Week High/Low31.36 - 48.58
Open / Close44.03 / 44.48
Float / Outstanding117.4M / 137.9M
Vol / Avg.1.1M / 1.1M
Mkt Cap6.1B
P/E14.93
50d Avg. Price43.61
Div / Yield-
Payout Ratio-
EPS0.44
Total Float117.4M

Halozyme Therapeutics (NASDAQ:HALO), Quotes and News Summary

Halozyme Therapeutics (NASDAQ: HALO)

Day High/Low43.46 - 44.64
52 Week High/Low31.36 - 48.58
Open / Close44.03 / 44.48
Float / Outstanding117.4M / 137.9M
Vol / Avg.1.1M / 1.1M
Mkt Cap6.1B
P/E14.93
50d Avg. Price43.61
Div / Yield-
Payout Ratio-
EPS0.44
Total Float117.4M
Benzinga - Jun 7, 2022, 8:35AM
Benzinga - May 26, 2022, 8:50AM
Benzinga - May 11, 2022, 8:41AM
Benzinga - May 10, 2022, 4:28PM
Benzinga - May 10, 2022, 4:28PM
Benzinga - May 10, 2022, 4:27PM
Benzinga - Apr 26, 2022, 8:15AM
Benzinga - Apr 13, 2022, 10:40AM
Benzinga - Apr 13, 2022, 7:43AM
Benzinga - Apr 13, 2022, 6:02AM
Benzinga - Apr 13, 2022, 5:10AM
Benzinga - Apr 8, 2022, 12:10PM
Benzinga - Apr 7, 2022, 7:46PM
Benzinga - Mar 24, 2022, 10:41AM
Benzinga - Mar 24, 2022, 8:02AM
Benzinga - Mar 22, 2022, 12:22PM
Benzinga - Feb 23, 2022, 6:44AM
Benzinga - Feb 22, 2022, 4:22PM
Benzinga - Feb 2, 2022, 4:45PM
Benzinga - Jan 10, 2022, 8:47AM
Benzinga - Dec 10, 2021, 10:59AM
Benzinga - Dec 9, 2021, 4:05PM
load more
Sector: Health Care.Industry: Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS0.4900.470 -0.0200
REV128.250M117.279M-10.971M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Halozyme Therapeutics Questions & Answers

Q
How do I buy Halozyme Therapeutics (HALO) stock?
A

You can purchase shares of Halozyme Therapeutics (NASDAQ: HALO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Halozyme Therapeutics's (HALO) competitors?
Q
What is the target price for Halozyme Therapeutics (HALO) stock?
A

The latest price target for Halozyme Therapeutics (NASDAQ: HALO) was reported by Goldman Sachs on Thursday, May 26, 2022. The analyst firm set a price target for 60.00 expecting HALO to rise to within 12 months (a possible 34.89% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Halozyme Therapeutics (HALO)?
A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $44.48 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Halozyme Therapeutics (HALO) pay a dividend?
A

There are no upcoming dividends for Halozyme Therapeutics.

Q
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
A

Halozyme Therapeutics’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Halozyme Therapeutics (HALO) going to split?
A

There is no upcoming split for Halozyme Therapeutics.

Q
What sector and industry does Halozyme Therapeutics (HALO) operate in?
A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.